BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 30076614)

  • 1. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
    Arora V; Maiwall R; Rajan V; Jindal A; Muralikrishna Shasthry S; Kumar G; Jain P; Sarin SK
    Hepatology; 2020 Feb; 71(2):600-610. PubMed ID: 30076614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).
    Jindal A; Singh H; Kumar G; Arora V; Sharma MK; Maiwall R; Rajan V; Tewathia HV; Vasishtha C; Sarin SK
    Dig Dis Sci; 2024 Jun; 69(6):2204-2214. PubMed ID: 38637454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
    Kulkarni AV; Ravikumar ST; Tevethia H; Premkumar M; Kumar K; Sharma M; Gupta R; Rao PN; Reddy DN
    Sci Rep; 2022 Apr; 12(1):5503. PubMed ID: 35365736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure.
    Jindal A; Bhadoria AS; Maiwall R; Sarin SK
    Liver Int; 2016 Jan; 36(1):59-67. PubMed ID: 26081914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
    Jiang QQ; Han MF; Ma K; Chen G; Wan XY; Kilonzo SB; Wu WY; Wang YL; You J; Ning Q
    World J Gastroenterol; 2018 Jun; 24(21):2300-2310. PubMed ID: 29881239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
    Sharma P; Kumar A; Shrama BC; Sarin SK
    Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.
    Wong F; Boyer TD; Sanyal AJ; Pappas SC; Escalante S; Jamil K
    Nephrol Dial Transplant; 2020 Sep; 35(9):1554-1561. PubMed ID: 30887050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Piano S; Gambino C; Vettore E; Calvino V; Tonon M; Boccagni P; Gringeri E; Germani G; Burra P; Cillo U; Angeli P
    Hepatology; 2021 May; 73(5):1909-1919. PubMed ID: 32870499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.
    Piano S; Schmidt HH; Ariza X; Amoros A; Romano A; Hüsing-Kabar A; Solà E; Gerbes A; Bernardi M; Alessandria C; Scheiner B; Tonon M; Maschmeier M; Solè C; Trebicka J; Gustot T; Nevens F; Arroyo V; Gines P; Angeli P;
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1792-1800.e3. PubMed ID: 29391267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.
    Solé C; Solà E; Huelin P; Carol M; Moreira R; Cereijo U; Mas JM; Graupera I; Pose E; Napoleone L; dePrada G; Juanola A; Fabrellas N; Torres F; Morales-Ruiz M; Farrés J; Jiménez W; Ginès P
    Liver Int; 2019 Jul; 39(7):1246-1255. PubMed ID: 30597709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: A randomized controlled study.
    Saif RU; Dar HA; Sofi SM; Andrabi MS; Javid G; Zargar SA
    Indian J Gastroenterol; 2018 Sep; 37(5):424-429. PubMed ID: 30178092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
    Olson JC; Subramanian RM
    PLoS One; 2024; 19(1):e0296690. PubMed ID: 38285703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Pharmacologic Therapies for Hepatorenal Syndrome-Acute Kidney Injury.
    Duong N; Kakadiya P; Bajaj JS
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10S):S27-S34. PubMed ID: 37625864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI).
    Kulkarni AV; Lee J; Reddy KR
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1067-1079. PubMed ID: 37856367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenaline is as Effective as Terlipressin in Hepatorenal Syndrome Type 1: A Prospective, Randomized Trial.
    Goyal O; Sidhu SS; Sehgal N; Puri S
    J Assoc Physicians India; 2016 Sep; 64(9):30-35. PubMed ID: 27762512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of terlipressin and noradrenaline versus terlipressin in hepatorenal syndrome with early non-response to terlipressin infusion:  A randomized trial.
    Singh V; Jayachandran A; De A; Singh A; Chandel S; Sharma N
    Indian J Gastroenterol; 2023 Jun; 42(3):388-395. PubMed ID: 37145232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.
    Erstad BL
    Ann Pharmacother; 2024 Feb; 58(2):156-164. PubMed ID: 37271967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.
    Ghosh S; Choudhary NS; Sharma AK; Singh B; Kumar P; Agarwal R; Sharma N; Bhalla A; Chawla YK; Singh V
    Liver Int; 2013 Sep; 33(8):1187-93. PubMed ID: 23601499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.